AGIO
AGIO
NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

$27.79
+0.26 (+0.94%)
As of May 10, 10:07 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target -60.9% upside
Low Target $8.41
Average Target $10.87
High Target $14.57
Current Price $27.79
Current
$27.79
Target
$10.87
$8.41 $10.87 avg $14.57
Scenario Analysis
Bear Case
$8.41
-69.7%
Low target
Base Case
$10.87
-60.9%
Avg target
Bull Case
$14.57
+-47.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$46.00
-39.6% from high
52-Week Low
$22.24
+25.0% from low
Target vs 52W High
$10.87
-76.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%